XEN-445
CAS No. 1515856-92-4
XEN-445( XEN445 | XEN 445 | XEN-445 )
Catalog No. M17330 CAS No. 1515856-92-4
XEN445, a potent and selective endothelial lipase(EL) inhibitor (IC50=0.237 uM), exhibitis good ADME and PK properties.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 31 | In Stock |
|
| 5MG | 50 | In Stock |
|
| 10MG | 95 | In Stock |
|
| 25MG | 178 | In Stock |
|
| 50MG | 332 | In Stock |
|
| 100MG | 514 | In Stock |
|
| 500MG | 1107 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameXEN-445
-
NoteResearch use only, not for human use.
-
Brief DescriptionXEN445, a potent and selective endothelial lipase(EL) inhibitor (IC50=0.237 uM), exhibitis good ADME and PK properties.
-
DescriptionXEN445 is potent and selective endothelial lipase inhibitor, that showed good ADME and PK properties, and demonstrated in vivo efficacy in raising plasma HDLc concentrations in mice. Endothelial lipase (EL) activity has been implicated in HDL metabolism and in atherosclerotic plaque development; inhibitors are proposed to be efficacious in the treatment of dyslipidemia related cardiovascular disease.
-
In Vitro——
-
In Vivo——
-
SynonymsXEN445 | XEN 445 | XEN-445
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
Recptorendothelial lipase
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number1515856-92-4
-
Formula Weight366.33
-
Molecular FormulaC18H17F3N2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 40 mg/mL. 109.19 mM
-
SMILESc1(ccc(c(c1)C(=O)O)N1C[C@H](CC1)OCc1ncccc1)C(F)(F)F
-
Chemical Name(S)-2-(3-(pyridin-2-ylmethoxy)pyrrolidin-1-yl)-5-(trifluoromethyl)benzoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sun S, et al. Bioorg Med Chem. 2013, 21(24), 7724-7734.
molnova catalog
related products
-
Dehydroaripiprazole
Dehydroaripiprazole is the active metabolite of aripiprazole. Aripiprazole is an antipsychotic drug, which is metabolized by CYP3A4 and CYP2D6 and mainly forms dehydroaripiprazole.
-
glucosylvitexin
Glucosylvitexin inhibits TPO activity.
-
GR 46611
GR 46611 is a selective 5-HT1B and 5-HT1D receptor agonist and can be used in studies about the treatment of epilepsy.
Cart
sales@molnova.com